Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22228955 | 1.00 | CYP2C19 (0.42) | CYP2C19LMNATSHRTRPA1CYP3A4 | |
| SCHEMBL22242500 | 0.77 | CYP2C19 (0.41) | CYP2C19LMNATSHRTRPA1CYP3A4 | |
| SCHEMBL22242503 | 0.77 | CYP2C19 (0.41) | CYP2C19LMNATSHRTRPA1CYP3A4 | |
| SCHEMBL22228963 | 0.77 | CYP2C19 (0.41) | CYP2C19LMNATSHRTRPA1CYP3A4 | |
| SCHEMBL30105471 | 0.74 | CYP2C19 (0.40) | CYP2C19LMNATSHRTRPA1ALOX15 | |
| 5Alpha-Hydroxy-14-Eudesm-11-En-3-One SCHEMBL24483235 | 0.72 | CYP2C19 (0.39) | CYP2C19 | |
| 5Alpha-Hydroxy-14-Eudesm-11-En-3-One SCHEMBL24483206 | 0.72 | CYP2C19 (0.39) | CYP2C19 | |
| SCHEMBL22242502 | 0.70 | CYP2C19 (0.37) | CYP2C19LMNATSHRTRPA1ALOX15 | |
| SCHEMBL22242504 | 0.70 | CYP2C19 (0.37) | CYP2C19LMNATSHRTRPA1ALOX15 | |
| SCHEMBL22228948 | 0.70 | CYP2C19 (0.37) | CYP2C19LMNATSHRTRPA1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200229474-A1 | NOVEL SPIROSESQUITERPENE COMPOUND, FLAVORING COMPOSITION AND FOOD/DRINK CONTAINING SAID COMPOUND, AND METHOD FOR PRODUCING SAID FOOD/DRINK | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200229474-A1 | NOVEL SPIROSESQUITERPENE COMPOUND, FLAVORING COMPOSITION AND FOOD/DRINK CONTAINING SAID COMPOUND, AND METHOD FOR PRODUCING SAID FOOD/DRINK | TAS2R20, TAS2R5, TAS2R13 | CYP2C19 3442/4885LMNA 1871/4885TSHR 3165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.